- Exclusive: US FDA to ask Sarepta to stop shipments of gene therapy Elevidys, source says Reuters
- Sarepta shares plunge 40% as future of its gene therapy appears at risk CNBC
- FDA to Ask Sarepta to Stop Shipping Muscular Dystrophy Drug Elevidys The New York Times
- Third death from a Sarepta gene therapy BioCentury
- FDA Is Investigating If Sarepta’s Gene Therapy Should Stay on Market Bloomberg
Source link
